Resources for Parents with Infants in the Neonatal Intensive Care Unit
List of resources for families with infants in the Neonatal Intensive Care Unit.
FDA Approves Zuranolone for the Treatment of Postpartum Depression
The FDA approves zuranolone, a new option for the treatment of PPD, a rapidly acting antidepressant with a good safety profile.
More Data on Zuranolone for Postpartum Depression: When Will It Hit the Market?
In women with severe postpartum depression, zuranolone was associated with improvements in depression beginning at day 3. FDA to make a decision next week.
Post-Marketing Safety Data for Brexanolone (Zulresso)
In this postmarketing surveillance data analysis, excessive sedation and loss of consciousness when receiving brexanolone occurred at lower rates than previously reported in clinical trials.
New Phone Number for the Maternal Mental Health Hotline: 1-833-TLC-MAMA
This hotline will offer a range of support, including brief interventions, referrals to both community-based and telehealth providers as needed.
Coach-Supported Web-Based Intervention for Mild to Moderate Postpartum Depression
This preliminary study suggests that web-based interventions with coaching are feasible, acceptable, and potentially effective treatment options for women with mild to moderate postpartum depression and/or anxiety.
Single Day CBT-Based Workshops for Mothers with Postpartum Depression
In this randomized controlled trial, a CBT-based workshop for women with PPD led to clinically meaningful reductions in depression and anxiety.
On Postpartum Psychosis Awareness Day: Educating Mothers, Families, and Health Care Providers
Postpartum psychosis is the most severe form of postpartum psychiatric illness. What are the signs and symptoms?
Zuranolone Improves Anxiety Symptoms and Insomnia in Women with Postpartum Depression
In women with postpartum depression, zuranolone was associated with concurrent improvements in depression, anxiety symptoms, and insomnia beginning at day 3.
Maternal Mental Health Awareness Week: May 1-7, 2023
May 4, 2022 is World Maternal Mental Health Day, coming together to increase awareness of perinatal mood and anxiety disorders.